Skip to main content
YOGI LIMITED logo

YOGI LIMITED — Investor Relations & Filings

Ticker · 511702 ISIN · INE290E01011 LEI · 89450035XQOCFHPRP114 BSE.NS Manufacturing
Open in API
Filings indexed 510 across all filing types
Latest filing 2023-05-31 Regulatory Filings
Country IN India
Listing BSE.NS 511702

About YOGI LIMITED

http://yogiltd.com/

Yogi Limited is an enterprise primarily engaged in the manufacturing and distribution of specialty chemicals and chemical intermediates. The company focuses on the production of various chemical formulations used across diverse industrial applications. Its operations encompass the sourcing, processing, and trading of chemical products, catering to both domestic and international markets. Originally established with a focus on cosmetic-related chemical products, the firm has expanded its portfolio to include a broader range of industrial chemical solutions. The company emphasizes quality control and technical expertise in its manufacturing processes to meet specific client requirements. Its business model integrates manufacturing capabilities with a robust supply chain for the efficient delivery of chemical raw materials and finished goods.

Recent filings

Filing Released Lang Actions
Disclosure under Regulation 7 (2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015-continual disclosure
Regulatory Filings
2023-05-31 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ghanshyambhai Nanjibhai Patel & PACs
Regulatory Filings
2023-05-31 English
YOGI Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/06/2023 ,inter alia, to consider and approve 1. Increase in authorized share capital ....
Regulatory Filings
2023-05-30 English
We would like to inform you that pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, the Board of ....
Capital/Financing Update Classification · 95% confidence The document is an official announcement from a company to the stock exchange (BSE Limited) regarding the outcome of a Board Meeting where the company allotted 50,96,470 equity shares upon conversion of convertible warrants. It details the number of shares allotted, names of allottees, the increase in paid-up share capital, and compliance with SEBI regulations. The document includes disclosures as per SEBI circular CIR/CFD/CMD/4/2015 about preferential allotment and conversion of warrants. There are no financial statements or detailed financial analysis present, only an update on share allotment and capital structure changes. This fits the category of a Capital/Financing Update (CAP) as it relates to company fundraising and capital structure changes through share allotment upon warrant conversion.
2023-05-29 English
We would like to inform you that pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, the Board of ....
Share Issue/Capital Change Classification · 95% confidence The document is an official announcement from a company to the stock exchange (BSE Limited) regarding the outcome of a Board Meeting where the company allotted 50,96,470 equity shares upon conversion of convertible warrants. It details the number of shares allotted, names of allottees, the increase in paid-up share capital, and compliance with SEBI regulations. The document is focused on the allotment of shares and conversion of warrants, which is a capital structure change. It is not a full financial report, earnings release, or management discussion. It is also not a proxy, AGM material, or legal proceeding. The document is a regulatory announcement about a capital change event, specifically a share allotment upon conversion of warrants. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length (8800 characters) and content confirm it is the announcement itself, not just a notice of a report publication or a certification. Confidence is high due to clear regulatory references and detailed share allotment information.
2023-05-29 English
Please find enclosed statement of deviation or variation under Regulation 32 (1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI circular No. CIR/CFD/CMDI/162/2019
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It provides a statement of deviation or variation in the utilization of funds raised through preferential allotment of convertible warrants. The document includes details such as the amount raised, dates of allotment, and confirmation that there is no deviation in the use of funds. It is a regulatory compliance disclosure related to capital raising activities rather than a full financial report or earnings release. The document is relatively short (5394 characters) and serves as an official regulatory filing to the stock exchange. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories like Capital/Financing Update (CAP) or Earnings Release (ER).
2023-05-24 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.